A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of bevacizumab in women with
lymphedema as a result of previous treatment for breast cancer.